Delta-like Ligand-3 modulator therapy(3B Pharmaceuticals)

N/A

Report date: 2025/03/20 16:14:30
NME

Base Information

Drug NameDelta-like Ligand-3 modulator therapy(3B Pharmaceuticals)
Drug Alias NameN/A
ClassificationRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionDelta-like protein 3 modulators
TargetsDelta-like protein 3
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies3B Pharmaceuticals GmbH
China Registration ClassN/A

Develop Information

Active Companies3B Pharmaceuticals GmbH
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A